Macquarie Group LTD Becton Dickinson & CO Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Macquarie Group LTD holds 96,650 shares of BDX stock, worth $23.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
96,650
Previous 88,796 8.84%
Holding current value
$23.3 Million
Previous $22 Million 2.8%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$225.07 - $246.17 $1.77 Million - $1.93 Million
7,854 Added 8.84%
96,650 $22.6 Million
Q1 2024

May 14, 2024
BUY
$233.45 - $247.73 $3.06 Million - $3.25 Million
13,127 Added 17.35%
88,796 $22 Million
Q4 2023

Feb 14, 2024
BUY
$232.24 - $267.23 $2.22 Million - $2.55 Million
9,561 Added 14.46%
75,669 $18.5 Million
Q3 2023

Nov 14, 2023
BUY
$254.9 - $283.59 $8.28 Million - $9.22 Million
32,500 Added 96.7%
66,108 $17.1 Million
Q2 2023

Aug 14, 2023
SELL
$238.39 - $265.32 $352,817 - $392,673
-1,480 Reduced 4.22%
33,608 $8.87 Million
Q1 2023

May 15, 2023
BUY
$229.71 - $259.35 $87,519 - $98,812
381 Added 1.1%
35,088 $8.69 Million
Q4 2022

Feb 21, 2023
BUY
$218.29 - $256.91 $576,940 - $679,013
2,643 Added 8.24%
34,707 $8.83 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $829,696 - $4.3 Million
-16,259 Reduced 33.65%
32,064 $7.15 Million
Q2 2022

Aug 15, 2022
SELL
$234.74 - $275.42 $1.34 Million - $1.57 Million
-5,704 Reduced 10.56%
48,323 $11.9 Million
Q1 2022

May 16, 2022
SELL
$243.64 - $270.48 $999,898 - $1.11 Million
-4,104 Reduced 7.06%
54,027 $14.4 Million
Q4 2021

Feb 11, 2022
BUY
$230.08 - $250.94 $3.45 Million - $3.76 Million
15,002 Added 34.78%
58,131 $14.6 Million
Q3 2021

Nov 12, 2021
BUY
$232.72 - $256.47 $77,728 - $85,660
334 Added 0.78%
43,129 $10.6 Million
Q2 2021

Aug 13, 2021
BUY
$232.65 - $254.58 $1.52 Million - $1.66 Million
6,520 Added 17.97%
42,795 $10.4 Million
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $298,699 - $330,604
-1,287 Reduced 3.43%
36,275 $8.82 Million
Q4 2020

Feb 16, 2021
SELL
$221.92 - $245.94 $7,323 - $8,116
-33 Reduced 0.09%
37,562 $9.4 Million
Q3 2020

Nov 13, 2020
BUY
$215.77 - $276.76 $94,723 - $121,497
439 Added 1.18%
37,595 $8.75 Million
Q2 2020

Aug 11, 2020
SELL
$219.9 - $263.41 $6.17 Million - $7.39 Million
-28,041 Reduced 43.01%
37,156 $8.89 Million
Q1 2020

May 15, 2020
SELL
$195.69 - $279.01 $9.92 Million - $14.1 Million
-50,695 Reduced 43.74%
65,197 $15 Million
Q4 2019

Feb 14, 2020
BUY
$236.45 - $266.82 $4.27 Million - $4.81 Million
18,040 Added 18.44%
115,892 $31.5 Million
Q3 2019

Nov 14, 2019
SELL
$230.58 - $256.08 $1.84 Million - $2.05 Million
-7,994 Reduced 7.55%
97,852 $24.8 Million
Q2 2019

Aug 14, 2019
SELL
$217.4 - $246.08 $1.47 Million - $1.66 Million
-6,750 Reduced 5.99%
105,846 $26.7 Million
Q1 2019

May 15, 2019
BUY
$206.05 - $248.17 $4.97 Million - $5.99 Million
24,129 Added 27.27%
112,596 $28.1 Million
Q4 2018

Feb 15, 2019
SELL
$204.73 - $257.93 $839,393 - $1.06 Million
-4,100 Reduced 4.43%
88,467 $19.9 Million
Q3 2018

Nov 15, 2018
SELL
$233.07 - $256.0 $4.97 Million - $5.45 Million
-21,307 Reduced 18.71%
92,567 $24.2 Million
Q2 2018

Aug 14, 2018
BUY
$208.1 - $233.85 $561,870 - $631,395
2,700 Added 2.43%
113,874 $27.3 Million
Q1 2018

May 11, 2018
BUY
$205.46 - $240.27 $2.34 Million - $2.74 Million
11,407 Added 11.43%
111,174 $24.1 Million
Q4 2017

Feb 15, 2018
BUY
$189.0 - $222.64 $1.19 Million - $1.41 Million
6,314 Added 6.76%
99,767 $23.1 Million
Q3 2017

Nov 08, 2017
BUY
$186.89 - $198.9 $17.5 Million - $18.6 Million
93,453
93,453 $18.3 Million

Others Institutions Holding BDX

# of Institutions
1,733
Shares Held
252M
Call Options Held
586K
Put Options Held
649K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email